tirzepatide norge First Time Tirzepatide cuts risk of diabetes

Tirzepatide slows gastric emptying, and dehydration compounds the constipation and nausea that can result

Adverse Reactions in Patients with Obstructive Sleep Apnea ZEPBOUND was evaluated in 2 randomized, double-blind, placebo-controlled trials (Study 5 and Study 6) that included a total of 467 adult patients with moderate to severe OSA and obesity [see Clinical Studies (14.2)]

None of these medications should be used during pregnancy or breastfeeding

43 In a phase 3 trial including patients with obesity (excluding T2DM), the highest dose group achieved a mean weight reduction of 11.2% by week 72

Fatigue or tiredness is recognised as a common adverse reaction in the UK Summary of Product Characteristics (SmPC), particularly in clinical trials for weight management

Enhanced formulation